Latest News

Pangaea helps launch new medication assisted treatment center for people who inject drugs in Tanzania. Pangaea’s Barrot Lambdin and consultant expert Doug Bruce support the Drug Control Commission of Tanzania in scaling up comprehensive drug use and HIV programs, with the launch of a second methadone clinic at Mwananyamala Regional Hospital. For more information about this project and our work in Tanzania, please contact Barrot Lambdin at: This email address is being protected from spambots. You need JavaScript enabled to view it.

The launch has so far been covered in the following articles/blogs:

by Josh Kron

KAMPALA, Uganda — Uganda’s sharp reduction of its AIDS rate has long been hailed as a Cinderella success story, inspiring a wave of aid programs and public health strategies to fight the disease across the developing world.

Please read this story published in the New York Times on Thursday, August 2nd 2012.

Preparations for the upcoming XIX International AIDS Conference in Washington DC, USA were given a boost this week by the announcement by the US Food and Drug Administration (FDA) that it has approved a combination of antiretroviral drugs for use in HIV prevention. Truvada® (emtricitabine/tenofovir disoproxil fumarate) can now be used by adults who have not been infected with HIV but are at risk of contracting the disease.

"This is great news," said Ben Plumley, Chief Executive Officer of Pangaea. "It is no magic bullet, but is further evidence of a promising new HIV prevention approach, pre-exposure prophylaxis (PrEP). The challenge now is to ensure it is accessible and affordable, as part of a platform of services, to those all who need it most, especially in marginalized communities. "

The role of PrEP will be one of the key issues raised at the XIX International AIDS Conference, which opens on 22nd of July. It is the first major international AIDS conference to be held after the US dropped in 2010 its discriminatory ban on people with HIV entering the country. Up to 30,000 people from around the world will congregate in Washington DC to share the latest information on the AIDS epidemic, one of the greatest social and medical challenges facing the world.

Newly appointed Pangaea Managing Director, Ben Cheng said, "In the last decade, we have seen significant progress in the number of people living with HIV accessing life-saving medicines. However, these gains will be short-lived if we do not sustain global funding, expanded access to services and continued research and development into new medicines. These are priorities that must be raised at Washington."

David Barr, Senior Pangaea Consultant, added, "While communities of people with HIV are now widely understood to have played pivotal roles in mobilizing access to treatment, funding for these groups is under threat, as national and international HIV budgets are cut. Investing in communities saves lives and is the foundation for the long-term response to this epidemic."

Pangaea has a full calendar of activities at the Washington, DC International AIDS Conference, and will be providing regular updates which can be found here on our newly-updated website

Pangaea is a non-profit international organization committed to building partnerships to improve the lives of people living with and most at-risk of HIV, regardless of where they live, to ensure equitable access to prevention, testing, treatment and care.

Pangaea’s Vice President of Research and Programs, Dr. Megan Dunbar, is presenting at a policy event in Washington, DC “Promoting Gender Equality in National Responses to HIV/AIDS, ” co-organized by the International Council for Research on Women, Pangaea and the Global Fund to Fight AIDS, TB and Malaria. 

Dr Dunbar is presenting recent findings from Pangaea’s evaluation of the Global Fund’s Gender Equality and Sexual Orientation and Gender Identity Strategies (SOGI), developed to ensure thatservices and programs funded by the Global Fund would equitably serve girls and women, and sexual, and other, minorities. 

These strategies were ground-breaking when first approved by the Global Fund in 2008 and 2009 - as the first thematic priorities for the world’s only financing mechanism established to fund technically sound country proposals for AIDS, TB and Malaria. Through these strategies, the Global Fund sent a strong message to implementing countries, of the importance of meeting the health needs of populations too often overlooked in general population-based infectious disease strategies.

The Pangaea Global AIDS Foundation welcomes US President Obama’s World AIDS remarks, in which he recognized that both nationally, and internationally, the AIDS epidemic “is not over – not by a long shot”.

In particular, the President called for HIV treatment to be provided to an additional 6 million HIV positive people worldwide by 2013. This is in addition to US support – including through the Global Fund – for the treatment, currently, of nearly 6 million people across the world.

“President Obama’s remarks epitomize the sustained, real commitment we need from the leaders of countries – particularly major donors,” commented Ben Plumley, CEO of Pangaea. “With the Global Fund currently not able to fund the next round of grant making, his speech sends a strong message worldwide.”

37 million People worldwide are living with HIV (amfAR Statistics 2014: Worldwide)

16 million Women living with HIV (United Nations Statistics 2014)

15 million People living with HIV having access to antiretroviral therapy (amfAR Statistics 2014: Worldwide)

5,600 People Contract HIV every day - more than 230 every hour (amfAR Statistics 2014: Worldwide)